Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

News

FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply

Diana Ernst, RPh

January 23, 2023

Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.

News

Limited Drug Exposure Data Halt Accelerated Approval Attempt for Donanemab

Diana Ernst, RPh

January 20, 2023

Donanemab is an antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.

Medicine

Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults

Diana Ernst, RPh

January 19, 2023

Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.

Pediatrics

Adacel Approved for Use During Pregnancy to Prevent Pertussis in Infants

Diana Ernst, RPh

January 12, 2023

The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.

Medicine

Discontinuation of Several HIV Medications Reported to FDA

Diana Ernst, RPh

January 6, 2023

The HIV medications are all manufactured by ViiV Healthcare, a GlaxoSmithKline.

Medicine

Vraylar Approved as Adjunctive Therapy for Major Depressive Disorder

Diana Ernst, RPh

December 19, 2022

The approval was based on data from 2 trials in adults who met DSM-IV-TR or DSM-5 criteria for MDD and had an inadequate response to 1 to 3 courses of prior antidepressant therapy.

Dermatology

Delgocitinib Cream Significantly Improves Chronic Hand Eczema in Trial

Diana Ernst, RPh

December 6, 2022

The trial met its primary endpoint with a significantly larger proportion of delgocitnib-treated patients achieving treatment success.

Pediatrics

AAP Releases “Choosing Wisely” Recommendations for Pediatric Emergency Medicine

Diana Ernst, RPh

December 5, 2022

As part of the Choosing Wisely campaign, the American Academy of Pediatrics (AAP) has released a new list of 5 tests and procedures commonly ordered in pediatric emergency medicine that physicians and patients should question. Choosing Wisely is an American Board of Internal Medicine (ABIM) Foundation initiative that aims to promote discussions between clinicians and…

Oncology

Rezlidhia Approved for Relapsed/Refractory AML With IDH1 Mutation

Diana Ernst, RPh

December 5, 2022

Olutasidenib is a small-molecule inhibitor of mutated IDH1.

Medicine

Sulbactam-Durlobactam Gets Priority Review for Acinetobacter Infections

Diana Ernst, RPh

December 2, 2022

The investigational intravenous product is a combination of sulbactam, a β-lactam antibiotic, and durlobactam, a broad-spectrum β-lactamase inhibitor.

Next post in Medicine